The largest database of trusted experimental protocols

Bovine protein kinase a

Manufactured by Merck Group
Sourced in United States

Bovine protein kinase A is a lab equipment product used for the study of protein kinases in biological research. It is a purified enzyme derived from bovine tissues, which functions to catalyze the transfer of phosphate groups to specific target proteins. This product is intended for use in various biochemical and cell-based assays to investigate the role of protein kinase A in signaling pathways and cellular processes.

Automatically generated - may contain errors

3 protocols using bovine protein kinase a

1

Quantifying GPCR-mediated cAMP Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell lines, culture, and cAMP assay are all described in our previous work (Apostol et al., 2021 (link)). Briefly, human PAC1, VPAC1, and VPAC2 receptors expressed in CHO cells were used for all experiments. Cells were grown in 50:50 DMEM-F12 medium with 10% heat-inactivated fetal bovine serum, 1X penicillin-streptomycin supplement, and 500 μg/ml G418 (neomycin) to maintain selection (all from ThermoFisher) at 37°C with 5% CO2 atmosphere. For the cAMP assay, cells were seeded at 20,000 cells/well in a 96 well plate, recovered overnight, then serum starved for 4 h. The cells were then incubated with 500 μM IBMX for 20 min, followed by agonist concentration curves in 500 μM IBMX media for 10 min. The reaction was terminated, boiled, then collected, followed by competition with 7 μg of bovine protein kinase A (Sigma-Aldrich) and ∼1 pmol of 3H-cAMP (PerkinElmer). The assay was incubated at room temp for 1 h, then collected onto GF/B filter plates and the data read using a MicroBeta2 scintillation counter (PerkinElmer). The resulting data was fit to a 3 variable non-linear regression curve using GraphPad Prism, which resulted in potency (EC50) and efficacy (EMAX) measurements. Native PACAP1–27 was used as a positive control, and also used to define an EMAX level of 100%.
+ Open protocol
+ Expand
2

cAMP Assay for DOR Agonist Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
This assay was also carried out as reported in our previous work [31 (link)]. First, 20,000 cells/well were plated in a 96-well plate in growth medium as above for 24 h. Then, cells were serum-starved in DMEM/F12 for 4 h and then incubated with 500 μM IBMX for 20 min. Stimulation buffer contained 500 μM IBMX and 50 μM forskolin, which is a known cAMP inducer. Serial dilutions of SNC80, a known reference DOR agonist, or test compounds were added in stimulation buffer for 10 min. Then, incubation mixtures were halted by adding ice-cold assay buffer and heating the plate at 80 °C for 10 min. The plate was centrifuged at 4,000 rpm for 10 min at 4 °C; then, supernatants were transferred into a new 96-well plate. The supernatants were co-incubated with 1 pmol of 3H-cAMP (PerkinElmer #NET1161250UC) and 7 μg of bovine protein kinase A (Sigma-Aldrich, St. Louis, MO, USA) in 0.05% bovine serum albumin for 1 h at room temperature. Then, the reactions were collected and measured as above. The data were normalized to cAMP suppression caused by vehicle (0%) or 10 μM SNC80 (100%) and fit to a 3-variable (Hill Slope = 1) agonist curve by GraphPad Prism 9.0.
+ Open protocol
+ Expand
3

Quantifying GPCR-mediated cAMP Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell lines, culture, and cAMP assay are all described in our previous work (Apostol et al., 2021 (link)). Briefly, human PAC1, VPAC1, and VPAC2 receptors expressed in CHO cells were used for all experiments. Cells were grown in 50:50 DMEM-F12 medium with 10% heat-inactivated fetal bovine serum, 1X penicillin-streptomycin supplement, and 500 μg/ml G418 (neomycin) to maintain selection (all from ThermoFisher) at 37°C with 5% CO2 atmosphere. For the cAMP assay, cells were seeded at 20,000 cells/well in a 96 well plate, recovered overnight, then serum starved for 4 h. The cells were then incubated with 500 μM IBMX for 20 min, followed by agonist concentration curves in 500 μM IBMX media for 10 min. The reaction was terminated, boiled, then collected, followed by competition with 7 μg of bovine protein kinase A (Sigma-Aldrich) and ∼1 pmol of 3H-cAMP (PerkinElmer). The assay was incubated at room temp for 1 h, then collected onto GF/B filter plates and the data read using a MicroBeta2 scintillation counter (PerkinElmer). The resulting data was fit to a 3 variable non-linear regression curve using GraphPad Prism, which resulted in potency (EC50) and efficacy (EMAX) measurements. Native PACAP1–27 was used as a positive control, and also used to define an EMAX level of 100%.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!